RenovoRx, Inc. (RNXT)
NASDAQ·Healthcare·Biotechnology
$1.62
-4.91%
Mkt Cap $76.14M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.62
-4.91%
Mkt Cap $76.14M
Buy
4
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —